down arrow

Daito Pharmaceutical Co., Ltd.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: JP3486150000
JPY
1,305.00
-2 (-0.15%)

Dec 11

TKS

 Click here to see other stocks
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationScore
Click here to find our call on this stock
Strong Sell
Sell
Hold
Buy
Strong Buy

MarketsMojo — Loved in India, Now Global

The power of Mojo is now in 29 countries. Explore global equities with the same cutting-edge features you love.

Comparison
Company
Score
Quality
Valuation
Financial
Technical
Elan Corp.
Earth Corp.
ASKA Pharmaceutical Holdings Co., Ltd.
Zeria Pharmaceutical Co., Ltd.
Katakura Industries Co., Ltd.
Daito Pharmaceutical Co., Ltd.
KYORIN Pharmaceutical Co., Ltd.
CellSource Co., Ltd.
Torii Pharmaceutical Co., Ltd.
Seikagaku Corp.
SanBio Co., Ltd.
Why is Daito Pharmaceutical Co., Ltd. ?
1
High Management Efficiency with a high ROE of 7.51%
2
Company has very low debt and has enough cash to service the debt requirements
3
Poor long term growth as Net Sales has grown by an annual rate of 1.60% and Operating profit at -13.43% over the last 5 years
4
The company has declared Negative results for the last 14 consecutive quarters
  • NET PROFIT(HY) At JPY 1,073.46 MM has Grown at -37.33%
  • ROCE(HY) Lowest at 3.67%
  • DEBT-EQUITY RATIO (HY) Highest at 18.61 %
5
With ROE of 3.64%, it has a very attractive valuation with a 0.61 Price to Book Value
  • The stock is trading at a premium compared to its peers' average historical valuations
  • Over the past year, while the stock has generated a return of 23.58%, its profits have fallen by -39.9%
stock-recommendationReal-Time Research Report
Verdict Report
How much should you hold?
  1. Overall Portfolio exposure to Daito Pharmaceutical Co., Ltd. should be less than 10%
  2. Overall Portfolio exposure to Pharmaceuticals & Biotechnology should be less than 30%

(If sector exposure > 30%, please use optimiser tool to see which are the best stocks to hold in Pharmaceuticals & Biotechnology)

When to exit? - We will constantly monitor the company and suggest at the appropriate time to exit from the stock

Is Daito Pharmaceutical Co., Ltd. for you?

High Risk, Low Return

Absolute
Risk Adjusted
Volatility
Daito Pharmaceutical Co., Ltd.
23.58%
0.24
56.96%
Japan Nikkei 225
28.54%
1.11
25.75%
stock-recommendationQuality
stock-summaryManagement Risk
stock-summaryGrowth
stock-summaryCapital Structure
stock-recommendation
Quality grade scale :

Below Average, Average, Good, Excellent

Quality key factors
Factor
Value
Sales Growth (5y)
1.60%
EBIT Growth (5y)
-13.43%
EBIT to Interest (avg)
100.00
Debt to EBITDA (avg)
0.37
Net Debt to Equity (avg)
0.16
Sales to Capital Employed (avg)
0.79
Tax Ratio
40.30%
Dividend Payout Ratio
55.81%
Pledged Shares
0
Institutional Holding
0
ROCE (avg)
9.93%
ROE (avg)
7.51%
stock-recommendationValuation
Valuation Scorecard stock-summary
stock-recommendation
Valuation grade scale :

Very Risky, Risky, Very Expensive, Expensive, Fair, Attractive, Very Attractive

Valuation Key Factors stock-summary
Factor
Value
P/E Ratio
17
Industry P/E
Price to Book Value
0.61
EV to EBIT
14.84
EV to EBITDA
5.70
EV to Capital Employed
0.66
EV to Sales
0.81
PEG Ratio
NA
Dividend Yield
NA
ROCE (Latest)
4.46%
ROE (Latest)
3.64%
stock-recommendationTechnicals
Technical key factors
Indicator
Weekly
Monthly
MACD
Bullish
Mildly Bullish
RSI
No Signal
No Signal
Bollinger Bands
Bullish
Mildly Bullish
Moving Averages
Bullish (Daily)
KST
Mildly Bearish
Mildly Bullish
Dow Theory
Mildly Bullish
Mildly Bullish
OBV
No Trend
Bullish
stock-recommendation Technical Indicator Scale: Bearish, Mildly Bearish, Sideways, Mildly Bullish, Bullish  Turned 
Technical Movement
Analyse All Technical Factors stock-recommendation
stock-recommendationFinancial Trend
Financial Trend Scorecard stock-summary
stock-recommendation
Financial Trend scale:

Very Negative, Negative, Flat, Positive, Very Positive, Outstanding

5What is working for the Company
DIVIDEND PAYOUT RATIO(Y)

Highest at 76.53%

INVENTORY TURNOVER RATIO(HY)

Highest at 2.14%

DEBTORS TURNOVER RATIO(HY)

Highest at 2.74%

DIVIDEND PER SHARE(HY)

Highest at JPY 2.74

NET SALES(Q)

Highest at JPY 14,034 MM

-22What is not working for the Company
NET PROFIT(HY)

At JPY 1,073.46 MM has Grown at -37.33%

ROCE(HY)

Lowest at 3.67%

DEBT-EQUITY RATIO (HY)

Highest at 18.61 %

RAW MATERIAL COST(Y)

Grown by 23.64% (YoY

CASH AND EQV(HY)

Lowest at JPY 4,586 MM

INTEREST(Q)

Highest at JPY 38 MM

Here's what is working for Daito Pharmaceutical Co., Ltd.
Net Sales
Highest at JPY 14,034 MM
in the last five periods
MOJO Watch
Near term sales trend is positive

Net Sales (JPY MM)

Inventory Turnover Ratio
Highest at 2.14%
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its inventory faster

Inventory Turnover Ratio

Debtors Turnover Ratio
Highest at 2.74%
in the last five Semi-Annual periods
MOJO Watch
Company has been able to sell its Debtors faster

Debtors Turnover Ratio

Dividend per share
Highest at JPY 2.74
in the last five years
MOJO Watch
Company is distributing higher dividend from profits generated

DPS (JPY)

Dividend Payout Ratio
Highest at 76.53%
in the last five years
MOJO Watch
Company is distributing higher proportion of profits generated as dividend

DPR (%)

Depreciation
Highest at JPY 1,124 MM
in the last five periods
MOJO Watch
The expenditure on assets done by the company may have gone into operation

Depreciation (JPY MM)

Here's what is not working for Daito Pharmaceutical Co., Ltd.
Interest
At JPY 38 MM has Grown at 11.76%
period on period (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (JPY MM)

Net Profit
At JPY 1,073.46 MM has Grown at -37.33%
Year on Year (YoY)
MOJO Watch
Near term Net Profit trend is negative

Net Profit (JPY MM)

Debt-Equity Ratio
Highest at 18.61 % and Grown
In each half year in the last five Semi-Annual periods
MOJO Watch
The company is borrowing more to fund its operations; it's liquidity situation may be stressed

Debt-Equity Ratio

Interest
Highest at JPY 38 MM
in the last five periods and Increased by 11.76% (QoQ)
MOJO Watch
Rising interest cost signifies increased borrowings

Interest Paid (JPY MM)

Cash and Eqv
Lowest at JPY 4,586 MM
in the last six Semi-Annual periods
MOJO Watch
Short Term liquidity is deteriorating

Cash and Cash Equivalents

Raw Material Cost
Grown by 23.64% (YoY)
MOJO Watch
The company's ability to pass on the cost of raw materials to customers has deteriorated; this may lead to a fall in profit margin

Raw Material Cost as a percentage of Sales

Stock List
ABCDEFGHIJKLMNOPQRSTUVWXYZOther
Footer Logo
InfinHub Market Technologies FZ-LLC, Building-2, Unit 112, Dubai Internet City, Dubai, United Arab Emirates
GET THE MARKETSMOJO APP
Company
Stocks
Portfolio
Market
Webinars
"Investment in securities markets are subject to market risk. Read all the related documents carefully before investing."